V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20164935 | 20063329 | 1.67 | 77 | Neo-adjuvant (N) | 2019-10-02 | 2019-10-18 | ECX | N | N | ECX | 100971045 |
| 20164938 | 20063330 | 1.68 | 67.8 | Neo-adjuvant (N) | 2018-11-03 | 2018-12-01 | ECX | 02 | N | CAPECITABINE + GEMCITABINE | 100956590 |
| 20164941 | 20063331 | 1.72 | 82.45 | Adjuvant (A) | 2019-08-03 | 2019-08-26 | ECX | 02 | N | ECX | 100815710 |
| 20164943 | 20063332 | 1.6 | 54 | Palliative (P) | 2019-03-31 | 2019-04-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100243814 |
| 20164944 | 20063333 | 1.9 | 57.3 | Neo-adjuvant (N) | 2018-05-17 | 2018-05-24 | ECX | N | null | ECX | 100760024 |
| 20164951 | 20063334 | 1.87 | 73.2 | Neo-adjuvant (N) | 2018-02-08 | 2018-02-13 | ECX | 02 | N | ECX | 101797233 |
| 20164954 | 20063335 | 1.58 | 79.7 | Palliative (P) | 2016-03-03 | 2016-03-28 | ECX | N | N | ECX | 100050047 |
| 20164955 | 20063336 | 1.52 | 90.9 | null | 2019-02-06 | 2019-03-09 | ECX | null | N | ECX | 100864472 |
| 20164963 | 20063337 | 1.57 | 44 | Palliative (P) | 2016-10-22 | 2016-10-22 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100660129 |
| 20164969 | 20063338 | 1.65 | 125.15 | null | 2018-11-16 | 2018-11-16 | ECX | N | N | ECX | 100094440 |
| 20164970 | 20063339 | 1.69 | 71.5 | Palliative (P) | 2017-04-26 | 2017-05-10 | ECX | 2 | N | ECX | 100740532 |
| 20164974 | 20063340 | 1.62 | 68.9 | Adjuvant (A) | 2020-03-15 | 2020-04-05 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101579010 |
| 20164976 | 20063341 | 1.73 | 53.4 | Neo-adjuvant (N) | 2017-05-07 | 2017-05-18 | ECX | 2 | N | ECX | 101514538 |
| 20164979 | 20063342 | 1.83 | 98.3 | Palliative (P) | 2018-02-25 | 2018-03-12 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100887650 |
| 20164980 | 20063343 | 1.6 | 64.3 | Neo-adjuvant (N) | 2016-05-01 | 2016-05-28 | ECX | N | N | ECX | 100778647 |
| 20164982 | 20063344 | 1.71 | 67.3 | Palliative (P) | 2017-05-13 | 2017-06-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100468217 |
| 20164986 | 20063345 | 1.77 | 72.6 | Adjuvant (A) | 2020-02-29 | 2020-02-29 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101113713 |
| 20164988 | 20063346 | 1.91 | 77.5 | Neo-adjuvant (N) | 2017-07-25 | 2017-07-25 | ECX | null | N | ECX | 100249520 |
| 20164990 | 20063347 | 1.77 | 101.2 | Neo-adjuvant (N) | 2017-07-11 | 2017-07-21 | ECX | N | N | ECX | 100329651 |
| 20164991 | 20063348 | 1.54 | 62.2 | Adjuvant (A) | 2020-03-29 | 2020-04-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101357748 |
| 20164998 | 20063349 | 1.79 | 75.9 | Palliative (P) | 2019-03-08 | 2019-03-08 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101200979 |
| 20165005 | 20063350 | 1.8 | 81.6 | Palliative (P) | 2016-03-01 | 2016-03-06 | ECX | 02 | N | ECX | 100693058 |
| 20165007 | 20063351 | 1.59 | 84.6 | Palliative (P) | 2018-12-30 | 2018-12-31 | ECX | 02 | N | ECX | 100142755 |
| 20165017 | 20063352 | 1.6 | 64.15 | Palliative (P) | 2018-01-25 | 2018-02-07 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100897808 |
| 20165023 | 20063353 | 1.78 | 68.5 | Neo-adjuvant (N) | 2019-06-05 | 2019-06-12 | ECX | N | null | ECX | 101458964 |
| 20165028 | 20063354 | 1.63 | 60.6 | Adjuvant (A) | 2019-11-25 | 2019-12-16 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101160947 |
| 20165030 | 20063355 | 1.69 | 48.9 | Neo-adjuvant (N) | 2018-08-06 | 2018-08-06 | ECX | 02 | N | ECX | 101319130 |
| 20165035 | 20063356 | 1.55 | 95 | Neo-adjuvant (N) | 2017-10-04 | 2017-10-07 | ECX | 02 | N | ECX | 100371420 |
| 20165036 | 20063357 | 1.72 | 54.9 | Curative (C) | 2018-05-12 | 2018-06-01 | ECX | 2 | N | ECX | 101426504 |
| 20165039 | 20063358 | 1.7 | 105.4 | Palliative (P) | 2016-06-12 | 2016-06-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101576155 |
| 20165040 | 20063359 | 1.64 | 66.4 | Adjuvant (A) | 2018-08-05 | 2018-09-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101518647 |
| 20165049 | 20063360 | 1.8 | 62.6 | Palliative (P) | 2017-12-11 | 2017-12-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100669196 |
| 20165057 | 20063361 | 1.78 | 100.7 | Curative (C) | 2016-05-06 | 2016-05-10 | ECX | 02 | N | ECX | 101527019 |
| 20165058 | 20063362 | 1.75 | 46.2 | Neo-adjuvant (N) | 2019-08-11 | 2019-08-25 | ECX | N | N | ECX | 101020797 |
| 20165063 | 20063363 | 1.76 | 114 | Adjuvant (A) | 2017-07-10 | 2017-07-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101442388 |
| 20165067 | 20063364 | 1.52 | 75.2 | Neo-adjuvant (N) | 2017-05-27 | 2017-06-08 | ECX | N | N | ECX | 100454518 |
| 20165068 | 20063365 | 1.58 | 97.5 | Adjuvant (A) | 2018-08-17 | 2018-08-30 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101526581 |
| 20165077 | 20063366 | 1.52 | 74 | Adjuvant (A) | 2017-03-16 | 2017-04-14 | ECX | 02 | N | ECX | 101212102 |
| 20165082 | 20063367 | null | 82.2 | Neo-adjuvant (N) | 2017-09-07 | 2017-09-25 | ECX | 02 | N | ECX | 100987003 |
| 20165087 | 20063368 | 1.65 | 54.2 | Neo-adjuvant (N) | 2019-09-19 | 2019-09-30 | ECX | N | N | ECX | 100398275 |
| 20165092 | 20063369 | 1.53 | 66.1 | Adjuvant (A) | 2016-03-09 | 2016-03-13 | ECX | N | N | ECX | 100807769 |
| 20165093 | 20063370 | 1.72 | 87 | 03 | 2019-03-28 | 2019-04-17 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101094651 |
| 20165096 | 20063371 | 1.62 | 63.9 | Palliative (P) | 2019-02-05 | 2019-03-03 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100906050 |
| 20165102 | 20063372 | 1.74 | 77.3 | Neo-adjuvant (N) | 2017-09-27 | 2017-10-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101442788 |
| 20165107 | 20063373 | 1.61 | 84 | Neo-adjuvant (N) | 2016-09-01 | 2016-09-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100477246 |
| 20165110 | 20063374 | 1.79 | 62.6 | Neo-adjuvant (N) | 2016-08-03 | 2016-09-19 | ECX | N | N | ECX | 100718797 |
| 20165130 | 20063375 | 1.58 | 74.6 | Neo-adjuvant (N) | 2018-12-01 | 2018-12-07 | ECX | N | N | ECX | 100841005 |
| 20165133 | 20063376 | 1.74 | 68.7 | Neo-adjuvant (N) | 2017-07-20 | 2017-08-05 | ECX | N | null | ECX | 101869020 |
| 20165139 | 20063377 | 1.66 | 114 | Adjuvant (A) | 2018-02-27 | 2018-03-12 | ECX | N | N | ECX | 101018409 |
| 20165142 | 20063378 | 1.57 | 65 | Neo-adjuvant (N) | 2019-11-30 | 2019-12-03 | ECX | 02 | N | ECX | 101484651 |